Kazia Therapeutics Ltd Sponsored ADR (KZIA)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
13. 34
+0.22
+1.6768%
$
21.82M Market Cap
- P/E Ratio
- Div Yield
95,400 Volume
0 Eps
$ 13.12
Previous Close 
Want to track KZIA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
KZIA Earnings Reports FAQ
What is the earnings per share (EPS) for KZIA?
The current EPS is 0.
What is the company's earnings growth rate?
Kazia Therapeutics Ltd Sponsored ADR has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Kazia Therapeutics Ltd Sponsored ADR has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Kazia Therapeutics Ltd Sponsored ADR are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for KZIA at this time, as Kazia Therapeutics Ltd Sponsored ADR has no recent EPS data to calculate it.
